𝔖 Bobbio Scriptorium
✦   LIBER   ✦

T cell suppression by osteoclasts in vitro

✍ Scribed by Francesco Grassi; Cristina Manferdini; Luca Cattini; Anna Piacentini; Elena Gabusi; Andrea Facchini; Gina Lisignoli


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
443 KB
Volume
226
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

T cells are critical regulators of osteoclast differentiation and function in bone, but whether osteoclasts can, in turn, regulate T cell homing, and response to stimuli is unclear. To investigate whether osteoclasts are immune competent cells, the expression of HLA Class II and costimulatory receptors was evaluated by RT‐PCR and immunohistochemistry by comparing osteoclast precursors and mature osteoclasts. T‐cell‐attracting chemokines were measured in the supernatants of confluent cultures of osteoclasts and compared with mesenchymal stromal cells and osteoblasts. T cell proliferation, cytokine production, and apoptosis were assayed in co‐cultures with osteoclasts in the presence or absence of mitogenic stimuli. To define the mechanism of action of osteoclasts, cytokine‐blocking experiments were performed. Our findings revealed that mature osteoclasts constitutively expressed Class II HLA in the membrane and upregulate the expression of CD40 and CD80 during differentiation. Osteoclasts secreted high levels of most T cell chemoattractants and effectively retained T cells in adhesion assays. Moreover, the osteoclasts potently blunted T cell response to PHA and CD3/CD28 stimulation, thus inhibiting proliferation, suppressing T cell TNFα and IFNγ production and decreasing T cell apoptosis by a mostly cell‐contact independent mechanism. In conclusion, osteoclasts are immune‐competent cells which can retain T cells and suppress in vitro T cell response to proliferative stimuli. J. Cell. Physiol. 226: 982–990, 2011. © 2010 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


T cell suppression in vitro. I. Role in
✍ Marc Feldmann 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 744 KB

## Abstract Suppression of the antibody response by supraoptimal numbers of T helper cells was studied __in vitro__ and found to have both a specific and a nonspecific component. Suppression did not depend on direct cell contract of T and B cells, as supernatants of activated T cells were just as i

Oral squamous cell carcinoma cells induc
✍ Takeyuki Tada; Eijiro Jimi; Masato Okamoto; Satoru Ozeki; Koji Okabe 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 554 KB

## Abstract The invasion of oral squamous cell carcinoma (SCC) cells into the mandibular bone is a common clinical problem. It has been reported that BHY cells, a human oral SCC cell line, are capable of invading mandibular bone of nude mice. These results led us to examine possible mechanisms of o

In vivo tumor suppression activity by T
✍ Kihyun Lee; Hyun Jung Min; Eun Jung Jang; Jeong-Ho Hong; Eun Sook Hwang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 661 KB

## Abstract T‐box‐containing protein expressed in T cells (T‐bet) is a master transcription factor for the development of interferon (IFN) γ‐producing T helper 1 (Th1) cells and also functions in other immune cells including natural killer (NK), cytotoxic T lymphocytes and dendritic cells. T‐bet‐de

Generation of osteoclasts from hemopoiet
✍ G. Hattersley; T. J. Chambers 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

Osteoclasts are the cells that resorb bone. It is generally presumed, on the basis of indirect experiments, that they are derived from the hemopoietic stem cell. However, this origin has never been established. We have developed an assay for osteoclastic differentiation in which bone marrow cells ar

Activation of osteoclasts by interleukin
✍ S.W. Fox; K. Fuller; T.J. Chambers 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 1 views

Recently, it has been found that osteoclasts are induced and activated by osteoblastic cells through expression of receptor activator NF-kB ligand (RANKL), and that soluble recombinant RANKL, with M-CSF, can replace the need for osteoblastic cells in osteoclast formation. We exploited this opportuni